High-dose chemotherapy in metastatic breast cancer

On the basis of clinical trials reported so far, myeloablative high-dose chemotherapy is not superior to conventional chemotherapy for advanced breast cancer.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1998-02, Vol.351 (9100), p.386-387
Hauptverfasser:	Basade, Maheboob M, Gulati, Subhash C
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - administration & dosage Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - pathology Chemotherapy Clinical trials Combined Modality Therapy Female Humans Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	On the basis of clinical trials reported so far, myeloablative high-dose chemotherapy is not superior to conventional chemotherapy for advanced breast cancer.
ISSN:	0140-6736 1474-547X
DOI:	10.1016/S0140-6736(05)78349-5